Olaf P.
- Country
- Germany
- Department
- Hematology, Oncology and Tumorimmunology
Research Overview
- A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications
- Evaluation of RLS-0071 in Hospitalized Patients with Steroid-Refractory Acute Graft-versus-Host Disease: A Phase 2 Dose-Ranging Study
- Phase 3 Study of Ravulizumab in Thrombotic Microangiopathy Post-Hematopoietic Stem Cell Transplant in Adults and Adolescents
Data & Insights
Has run more than one trial at 150 of 203 partner sites.
Specializations
Graft-versus-Host Disease Management
The investigator specializes in treating both acute and chronic graft-versus-host disease, with particular emphasis on developing innovative therapeutic approaches for patients following transplantation procedures.
- Initial treatment strategies for aGVHD
- Steroid-refractory GVHD interventions
- Chronic GVHD therapeutic solutions
The research focus includes novel combination therapies with corticosteroids for managing GVHD manifestations.
Transplant Complications
Expertise in addressing post-transplant complications with a specific focus on thrombotic microangiopathy following hematopoietic stem cell transplantation.
- HSCT-associated complications
- Microangiopathy management
- Post-transplant care optimization
The investigator explores preventive strategies and therapeutic interventions for transplant-related complications.
Hematologic Applications
Focused on advancing treatment options for patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation.
- Microbiome-based therapies
- Novel immunological approaches
- Survival outcome improvement
Research encompasses innovative therapeutic strategies to enhance transplant outcomes in hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.